Update on reactive arthritis.
Sigal
L H
LH
Departments of Medicine, Pediatrics, and Molecular Genetics & Microbiology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D016918:Arthritis, Reactive / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology* / Q000503:physiopathology; D002690:Chlamydia Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D004359:Drug Therapy, Combination; D004756:Enterobacteriaceae Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D019317:Evidence-Based Medicine / Q000379:methods; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D008297:Male; D011379:Prognosis; D018570:Risk Assessment; D012460:Sulfasalazine / Q000008:administration & dosage; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D012460:Sulfasalazine